The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
108410825 10841082 5 F 2002 20160804 20150220 20160818 EXP BR-AMGEN-BRACT2012038812 AMGEN 59.00 YR A F Y 60.00000 KG 20160817 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
108410825 10841082 1 PS ENBREL ETANERCEPT 1 Subcutaneous 50 MG, WEEKLY Y 103795 50 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE /wk
108410825 10841082 2 SS ENBREL ETANERCEPT 1 Unknown 50 MG, WEEKLY Y 103795 50 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE /wk
108410825 10841082 3 SS PREDNISONE. PREDNISONE 1 Unknown 5 MG, DAILY 0 5 MG
108410825 10841082 4 C METHOTREXATE. METHOTREXATE 1 17.5 MG, WEEKLY 0 17.5 MG TABLET /wk
108410825 10841082 5 C METHOTREXATE. METHOTREXATE 1 17.5 MG, WEEKLY 0 17.5 MG TABLET /wk
108410825 10841082 6 C METHOTREXATE. METHOTREXATE 1 17.5 MG, WEEKLY 0 17.5 MG TABLET /wk
108410825 10841082 7 C RAMIPRIL. RAMIPRIL 1 5 MG , 1X/DAY 0 5 MG TABLET QD
108410825 10841082 8 C ATORVASTATIN ATORVASTATIN 1 20 MG , 1X/DAY 0 20 MG TABLET QD
108410825 10841082 9 C ATORVASTATIN ATORVASTATIN 1 20 MG , 1X/DAY 0 20 MG TABLET QD
108410825 10841082 10 C CLONAZEPAM. CLONAZEPAM 1 UNK 0
108410825 10841082 11 C CALCIUM CALCIUM 1 UNK 0
108410825 10841082 12 C OMEPRAZOL OMEPRAZOLE 1 UNK 0
108410825 10841082 13 C ATORVASTATIN CALCIUM. ATORVASTATIN CALCIUM 1 UNK 0
108410825 10841082 14 C ATORVASTATIN CALCIUM. ATORVASTATIN CALCIUM 1 UNK 0
108410825 10841082 15 C ATORVASTATIN CALCIUM. ATORVASTATIN CALCIUM 1 20 MG , 1X/DAY 0 20 MG QD
108410825 10841082 16 C LORATADINE. LORATADINE 1 UNK 0
108410825 10841082 17 C LORATADINE. LORATADINE 1 UNK 0
108410825 10841082 18 C LORATADINE. LORATADINE 1 UNK 0
108410825 10841082 19 C ARAVA LEFLUNOMIDE 1 20 MG , 1X/DAY 0 20 MG QD
108410825 10841082 20 C ARAVA LEFLUNOMIDE 1 20 MG , 1X/DAY 0 20 MG QD
108410825 10841082 21 C FLUOXETINE FLUOXETINE HYDROCHLORIDE 1 80 MG , 1X/DAY 0 80 MG QD
108410825 10841082 22 C FLUOXETINE FLUOXETINE HYDROCHLORIDE 1 80 MG , 1X/DAY 0 80 MG QD
108410825 10841082 23 C FLUOXETINE FLUOXETINE HYDROCHLORIDE 1 80 MG , 1X/DAY 0 80 MG QD
108410825 10841082 24 C SIMVASTATIN. SIMVASTATIN 1 UNK 0
108410825 10841082 25 C OMEPRAZOL OMEPRAZOLE 1 UNK 0
108410825 10841082 26 C PANTOPRAZOLE PANTOPRAZOLE SODIUM 1 UNK 0
108410825 10841082 27 C VITAMIN D CHOLECALCIFEROL 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
108410825 10841082 1 Rheumatoid arthritis
108410825 10841082 3 Rheumatoid arthritis
108410825 10841082 7 Blood pressure abnormal
108410825 10841082 21 Antidepressant therapy
108410825 10841082 24 Blood cholesterol abnormal
108410825 10841082 26 Gastritis

Outcome of event

Event ID CASEID OUTC COD
108410825 10841082 HO
108410825 10841082 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
108410825 10841082 Blood glucose abnormal
108410825 10841082 Condition aggravated
108410825 10841082 Crying
108410825 10841082 Decreased immune responsiveness
108410825 10841082 Depression
108410825 10841082 Dermatitis allergic
108410825 10841082 Dislocation of vertebra
108410825 10841082 Drug ineffective
108410825 10841082 Dyspnoea
108410825 10841082 Erythema
108410825 10841082 Feeling abnormal
108410825 10841082 Fungal skin infection
108410825 10841082 Herpes virus infection
108410825 10841082 Hypersensitivity
108410825 10841082 Hypothyroidism
108410825 10841082 Inflammation
108410825 10841082 Intervertebral disc injury
108410825 10841082 Intervertebral disc protrusion
108410825 10841082 Miliaria
108410825 10841082 Neuritis
108410825 10841082 Opportunistic infection
108410825 10841082 Osteopenia
108410825 10841082 Pain
108410825 10841082 Pharyngeal oedema
108410825 10841082 Rheumatoid arthritis
108410825 10841082 Tendon rupture
108410825 10841082 Throat tightness
108410825 10841082 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
108410825 10841082 1 201111 2012 0
108410825 10841082 2 2013 2014 0
108410825 10841082 3 1996 0
108410825 10841082 6 2012 0
108410825 10841082 7 2003 0
108410825 10841082 15 2004 0
108410825 10841082 20 2015 0
108410825 10841082 23 2012 0
108410825 10841082 24 2003 0
108410825 10841082 26 1998 0